The ImmunoVerse™

Dr. James Mulé, a leading immunotherapy researcher with three decades at the forefront, joins to reveal the transformative journey of T-cell therapies. He shares how initial skepticism led to pioneering work at the NCI, where he collaborated with legends like Steve Rosenberg. Mulé discusses groundbreaking advances in tumor-infiltrating lymphocytes, their FDA approval, and expanding their application beyond melanoma. He also highlights the potential of engineered immune strategies to tackle challenging cancers like pancreatic cancer, instilling hope in future therapies.

Dr. Phil Greenberg, a leading immunologist at Fred Hutchinson Cancer Center, shares his groundbreaking work on engineered T-cell therapies. He discusses the evolution from early graft-versus-leukemia insights to modern clinical successes. Listeners learn about innovative techniques like rewiring T cells to target tumors and using CRISPR for precise interventions. Greenberg highlights the importance of mentorship in science and advocates for better communication of research to the public. His vision for the future underscores a transformative potential for cancer treatment.

In this illuminating conversation, Dr. Steven A. Rosenberg, the Chief of the Surgery Branch at the National Cancer Institute, shares his pioneering journey in cancer immunotherapy. He discusses his early motivations and the moment he recognized the immune system's potential in battling cancer. Listeners will hear about his groundbreaking work with IL-2, tumor-infiltrating lymphocytes, and CAR-T therapies. Rosenberg also reflects on overcoming skepticism and his vision for the future of immunotherapy, emphasizing the importance of mentorship and persistence.

Dive into the fascinating world of immunotherapy, where cutting-edge science meets cancer treatment. Hear from pioneering experts discussing groundbreaking breakthroughs and the challenges they face. Explore the journey of innovation that is reshaping medicine and offering hope to patients. Join Dr. Patrick Hwu as he guides you through this essential conversation on the future of cancer care.